Overview

A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder

Status:
Completed
Trial end date:
2018-05-16
Target enrollment:
Participant gender:
Summary
A study to evaluate a drug (dasotraline) on the safety, effectiveness and how well the body tolerates it, in adults with moderate to severe binge eating disorder
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion